Dihexa mastery course
Unit 8 of 10

Safety & Side Effects

Dihexa has no formal human safety dataset at all. The most important safety issue is not a reported side effect but a t…

The c-Met oncology signal and the missing safety data

Dihexa has no formal human safety dataset at all. The most important safety issue is not a reported side effect but a theoretical one: c-Met is a proto-oncogene, and a molecule that potentiates it systemically carries a mechanism-intrinsic cancer concern.

This unit separates the thin anecdotal reports from the serious theoretical risks, features the oncology signal prominently, and closes on the grey-market product-quality problem. Education only, as always.

Key terms

The safety data gap


The c-Met oncology concern


The industry builds inhibitors, not potentiators


The broader theoretical risk map


Who should be most cautious


The grey-market quality problem